For the remainder of 2024, supply-side constraints, geopolitical risks and global economic trends will be in focus. The U.S.

Atkins “has been a strong supporter of the asset management industry and sympathizes with the challenges faced by the ...

Commodity trading advisors rebounded sharply in November, with several posting huge gains for the month. In fact, at least ...

The closure comes after the fund, which now manages more than $2.1 billion, posted another big gain. The fund is up a little ...

A report from EY says the industry has pivoted to individuals, but tapping and servicing these clients is expensive.

The newest episode of Alternative Angles features a conversation that highlights the differences—and similarities—between ...

But there are bright spots, including private credit and secondaries, which remain "key pillars of alternative asset allocation,” said Coller Capital’s Jeremy Coller.

In November, most biopharma and life sciences hedge funds were in the black, though not all have returned to their high-water marks. The funds were helped by the biopharma rebound that was mainly ...

Economic downturns have a way of separating good leaders from great ones. After two years of uncertainty surrounding Covid-19, Europe is lurching towards a recession. In March, the outbreak of ...

But with many institutions unable or unwilling to pony up more cash for new investments, the market is also being forced to change. The “playbook is now getting rewritten,” according to PitchBook ...

By clicking “Continue”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, ...